Bethany Davis, Ph.D.
Research Assistant Professor
Clinical Genomics and Therapeutics Division
Back

Dr. Bethany Davis, an enrolled member of Turtle Mountain Band of Chippewa Indians, is a Research Assistant Professor within the Clinical Genomics and Therapeutics Division. She has expertise in elucidating the effects of exposures to environmental toxicants (heavy metals) and hyperglycemia in the kidney; her primary research focus involves the molecular characterization of and studying mutational signatures associated with kidney cancer in Native Americans.

Her future goals are to capitalize on the advancements of technology to apply her training and knowledge of cancer genomics to improve precision medicine for Native Americans, ultimately, bridging the gap in health disparities.

Dr. Davis earned her Ph.D. in Biochemistry and Molecular Biology from the University of North Dakota School of Medicine and Health Sciences in 2018 studying the effects of hyperglycemia and cadmium exposures in a kidney in vitro cell model system.

Biggane JP, Ke X, Goldenstein BL, Davis KL, Luger EJ, Davis BA, Jurgens C, Perez DM, Porter JE, Doze VA. (2022). Pharmacological characterization of the α2A-adrenergic Receptor Inhibiting Rat Hippocampal CA3 Epileptiform Activity: Comparison of Ligan Efficacy and Potency. Journal of Receptors and Signal Transduction.

Shrestha S, Singhai S, Sens DA, Somji S, Davis BA, Guyer R, Breen S, Kalonick M, Garrett SH. (2020). Elevated Glucose Represses Lysosomal and mTOR Genes in Renal Epithelial Cells Composed of Progenitor CD133+ cells. PLOS ONE.

Gerhard GS, Davis B, Wu X, Hanson A, Wilhelmsen D, Piras IS, Still CD., Chu X, Petrick AT, DiStefano JK. (2020). Differentially Expressed mRNAs and LCRNAs Shared Between Activated Human Hepatic Stellate Cells and NASH Fibrosis. Biochemistry and Biophysics Reports. 

DiStefano JK and Davis B. (2019). Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma. Cancers. 11(4).

Doze VA, Papay RS, Goldenstein BL, Gupta MK, Collette KM, Nelson BW, Lyons MJ, Davis BA, Luger EJ, Wood SG, Haselton JR, Simpson PC, Perez DM. (2011). Longterm alpha 1A-Adrenergic Receptor Stimulations Improves Synaptic Plasticity, Cognitive Function, Mood, and Longevity. Molecular Pharmacology 80: 747-758.

We found 1 result matching most recent news articles for "Bethany Davis"

Get our stories delivered